Skip to content

← All stories

Markets

AstraZeneca scraps late-stage lung cancer trial after data setback

1 source ·3 articles ·1h ago

Covered by 1 outlet

All coverage · 3 articles

Investing.com Canada ·1h ago

AstraZeneca scraps late-stage lung cancer trial after data setback

Investing.com Stock Market ·1h ago

AstraZeneca scraps late-stage lung cancer trial after data setback

Investing.com Canada ·2h ago

AstraZeneca discontinues lung cancer trial of volrustomig